Trading for the period was in line with the Board's expectations, with total sales volumes ahead of the equivalent period last year, continuing the momentum delivered in H1.
The Devro 100 programme continues to progress well, with actions on track to deliver the anticipated cost savings for the year.
The Board's expectations for the year ending 31 December 2017 remain unchanged.
BHP Group plc Quarterly Production Update
Palace Capital plc Disposals and Debt Update
Carr’s Group plc Strategic Update and Interim Results
National Grid plc Pre-Close Update Ahead of 2023/24 Full Year Results
GSK plc Announce Additional Eagle-1 Results
GSK plc Announce Positive Data Relating to Shingrix Vaccine in the Protection against Shingles
Delivered to your inbox every Friday